Advertisement
Advertisement
Dr. Axe Wire · Food, herbs & supplements · gut
Nanoparticle Curcumin Eases Colitis In Mice By Reshaping Gut Bacteria
A lab-engineered form of curcumin protected mice from colitis, pointing to gut bacteria as the reason this compound struggles in regular supplement form.
A nanoparticle version of curcumin protected mice from ulcerative colitis by reshaping their gut bacteria, according to a study published October 13, 2026 in The American Journal of Chinese Medicine.
Researchers studied a murine model of dextran sulfate sodium-induced colitis, a standard lab method for triggering ulcerative colitis-like inflammation in mice. Sample size was not reported. Mice were pre-supplemented with nanoformulated curcumin, an engineered particle form designed to overcome curcumin's low solubility and poor absorption in its ordinary form, before colitis was induced. Treated mice showed reduced disease severity, less damage to the intestinal lining, and lower colon inflammation compared with untreated colitis mice. Using 16S rRNA sequencing, a method for identifying which bacterial species are present in a sample, and untargeted metabolomics, a technique measuring the small molecules those bacteria produce, the researchers found that nano-curcumin restored a more balanced mix of gut bacteria and increased production of short-chain fatty acids, byproducts of fiber fermentation linked to gut lining repair and lower inflammation.
The authors state that fecal microbiota transplants from nano-curcumin-treated mice into other colitis mice reproduced the protective effect, which they say confirms the gut bacteria changes drove the benefit rather than just accompanying it. Plain curcumin has long underperformed relative to its lab results because so little of it gets absorbed intact. Engineering it into a nanoparticle appears to be one way researchers are trying to get more of it where gut bacteria and gut tissue can use it.
Advertisement
dietary nano-CUR consumption protects against ulcerative colitis by modulating the gut microbiome and its metabolic output
The study authors did not report how many mice were used, and curcumin was given before colitis started rather than after symptoms appeared, so this does not test it as a treatment for existing flares. This is animal data in a chemically induced model, not a clinical trial, so it cannot establish a dose or outcome for people with ulcerative colitis.
Dr. Axe’s Take
This is a mechanism study, not permission to self-treat a colitis flare with curcumin off the shelf. Transplanting the gut bacteria alone reproduced the protection, which tells me the bacterial shift is doing real work rather than just riding along with the curcumin. Poor absorption has always been curcumin's biggest limitation in regular supplement form, which is why I favor curcumin paired with black pepper extract or formulated for bioavailability. If you have ulcerative colitis, keep working with your gastroenterologist, and talk to them before adding any curcumin product, since the timing and dose used here don't map onto human flares.
— Dr. AxeStory summary
- Who
- Mice with dextran sulfate sodium-induced colitis; sample size not reported
- Design
- Murine model of DSS-induced colitis; nano-curcumin given before colitis induction; gut bacteria and metabolites analyzed, with fecal transplant used to test causation
- Dose
- Not reported
- Primary result
- Nano-curcumin pre-supplementation reduced disease severity, intestinal barrier damage and colon inflammation versus untreated colitis mice
- Secondary
- Gut bacteria balance restored; short-chain fatty acid production increased; fecal transplant from treated mice reproduced the protective effect
- Funding / conflicts
- Funders listed in the journal record: National Natural Science Foundation of China; National Key Research and Development Program of China; “Pioneer” and “Leading Goose” R&D Program of Zhejiang; Joint Fund of Zhejiang Provincial Natural Science Foundation of China; Agricultural Science and Technology Program in Taizhou; Social Development Science and Technology Program in Taizhou, and 2 others. Conflicts not reported in the abstract.
- Date
- Oct 13, 2026